Clinical trial
Comparison of the Effects of Latanoprost(0.005%) and Brinzolamide(1.0%) on Intraocular Pressure in Primary Open-angle Glaucoma and Ocular Hypertension
NCT01084902 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Effects of Latanoprost(0.005%) and Brinzolamide(1.0%) on Intraocular Pressure in Primary Open-angle Glaucoma and Ocular Hypertension
- Lead sponsor
- Peking University First Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2010
- Completion date
- December 31, 2010
- Enrollment
- 130 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.